Home > Back to Publisher > Report Information

OTC Healthcare in Japan to 2011

Datamonitor
August 5, 2008
199 Pages - SKU: DFMN1872850

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Japan

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Japan. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in Japan increased between 2001-2006, growing at an average annual rate of 1.3%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Novartis AG with Daiichi Sankyo, Ltd. in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
: Pfizer Inc; Novartis AG
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
: Value; Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
: Product launches over time; Recent product launches
Chapter 17 JAPAN SOCIOECONOMIC PROFILE
: Country Overview; Key Facts; Political Overview; Japan Economic Overview
Chapter 18 JAPAN MACROECONOMIC PROFILE
: Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
CHAPTER 20 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: Japan OTC Healthcare value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 2: Japan OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: Japan OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: Japan Analgesics value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 5: Japan Analgesics category growth comparison, by value, 2001-2011; Figure 6: Japan Analgesics company share, by value, 2005-2006 (%); Figure 7: Japan Cough and Cold Preparations value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 8: Japan Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: Japan Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: Japan Traditional Medicines value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 11: Japan Traditional Medicines company share, by value, 2005-2006 (%); Figure 12: Japan First Aid Kits value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 13: Japan First Aid Kits company share, by value, 2005-2006 (%); Figure 14: Japan Indigestion Preparations value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 15: Japan Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 16: Japan Indigestion Preparations company share, by value, 2005-2006 (%); Figure 17: Japan Vitamins and Minerals value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 18: Japan Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 19: Japan Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 20: Japan Plasters & Bandages value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 21: Japan Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 22: Japan Plasters & Bandages company share, by value, 2005-2006 (%); Figure 23: Japan Medicated Skin Products value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 24: Japan Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 25: Japan Medicated Skin Products company share, by value, 2005-2006 (%); Figure 26: Japan Other OTC Healthcare Products value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 27: Japan Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 28: Japan Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 29: Japan Topical OTC Medicines value & value forecast, 2001-2011 (JPY m, nominal prices); Figure 30: Japan Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 31: Japan Topical OTC Medicines company share, by value, 2005-2006 (%); Figure 32: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 33: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 34: Map of Japan; Figure 35: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: Japan OTC Healthcare value, 2001-2006 (JPY m, nominal prices); Table 3: Japan OTC Healthcare value forecast, 2006-2011 (JPY m, nominal prices); Table 4: Japan OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: Japan OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: Japan OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: Japan OTC Healthcare value, by brand 2005-2006 (JPY m nominal prices); Table 8: Japan OTC Healthcare company share by value, 2005-2006 (%); Table 9: Japan OTC Healthcare value, by company, 2005-2006 (JPY m nominal prices); Table 10: Japan OTC Healthcare expenditure per capita, 2001-2006 (JPY, nominal prices); Table 11: Japan OTC Healthcare forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 12: Japan OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: Japan OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: Pfizer Inc Key Facts; Table 15: Novartis AG Key Facts; Table 16: Japan Analgesics value, 2001-2006 (JPY m, nominal prices); Table 17: Japan Analgesics value forecast, 2006-2011 (JPY m, nominal prices); Table 18: Japan Analgesics value, 2001-2006 (US$ m nominal prices); Table 19: Japan Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 20: Japan Analgesics brand share, by value, 2005-2006 (%); Table 21: Japan Analgesics value, by brand 2005-2006 (JPY m nominal prices); Table 22: Japan Analgesics company share by value, 2005-2006 (%); Table 23: Japan Analgesics value, by company, 2005-2006 (JPY m nominal prices); Table 24: Japan Analgesics expenditure per capita, 2001-2006 (JPY, nominal prices); Table 25: Japan Analgesics forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 26: Japan Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 27: Japan Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 28: Japan Cough and Cold Preparations value, 2001-2006 (JPY m, nominal prices); Table 29: Japan Cough and Cold Preparations value forecast, 2006-2011 (JPY m, nominal prices); Table 30: Japan Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 31: Japan Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 32: Japan Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 33: Japan Cough and Cold Preparations value, by brand 2005-2006 (JPY m nominal prices); Table 34: Japan Cough and Cold Preparations company share by value, 2005-2006 (%); Table 35: Japan Cough and Cold Preparations value, by company, 2005-2006 (JPY m nominal prices); Table 36: Japan Cough and Cold Preparations expenditure per capita, 2001-2006 (JPY, nominal prices); Table 37: Japan Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 38: Japan Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 39: Japan Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 40: Japan Traditional Medicines value, 2001-2006 (JPY m, nominal prices); Table 41: Japan Traditional Medicines value forecast, 2006-2011 (JPY m, nominal prices); Table 42: Japan Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 43: Japan Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 44: Japan Traditional Medicines brand share, by value, 2005-2006 (%); Table 45: Japan Traditional Medicines value, by brand 2005-2006 (JPY m nominal prices); Table 46: Japan Traditional Medicines company share by value, 2005-2006 (%); Table 47: Japan Traditional Medicines value, by company, 2005-2006 (JPY m nominal prices); Table 48: Japan Traditional Medicines expenditure per capita, 2001-2006 (JPY, nominal prices); Table 49: Japan Traditional Medicines forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 50: Japan Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 51: Japan Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 52: Japan First Aid Kits value, 2001-2006 (JPY m, nominal prices); Table 53: Japan First Aid Kits value forecast, 2006-2011 (JPY m, nominal prices); Table 54: Japan First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 55: Japan First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 56: Japan First Aid Kits brand share, by value, 2005-2006 (%); Table 57: Japan First Aid Kits value, by brand 2005-2006 (JPY m nominal prices); Table 58: Japan First Aid Kits company share by value, 2005-2006 (%); Table 59: Japan First Aid Kits value, by company, 2005-2006 (JPY m nominal prices); Table 60: Japan First Aid Kits expenditure per capita, 2001-2006 (JPY, nominal prices); Table 61: Japan First Aid Kits forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 62: Japan First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 63: Japan First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 64: Japan Indigestion Preparations value, 2001-2006 (JPY m, nominal prices); Table 65: Japan Indigestion Preparations value forecast, 2006-2011 (JPY m, nominal prices); Table 66: Japan Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 67: Japan Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 68: Japan Indigestion Preparations brand share, by value, 2005-2006 (%); Table 69: Japan Indigestion Preparations value, by brand 2005-2006 (JPY m nominal prices); Table 70: Japan Indigestion Preparations company share by value, 2005-2006 (%); Table 71: Japan Indigestion Preparations value, by company, 2005-2006 (JPY m nominal prices); Table 72: Japan Indigestion Preparations expenditure per capita, 2001-2006 (JPY, nominal prices); Table 73: Japan Indigestion Preparations forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 74: Japan Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 75: Japan Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 76: Japan Vitamins and Minerals value, 2001-2006 (JPY m, nominal prices); Table 77: Japan Vitamins and Minerals value forecast, 2006-2011 (JPY m, nominal prices); Table 78: Japan Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 79: Japan Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 80: Japan Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 81: Japan Vitamins and Minerals value, by brand 2005-2006 (JPY m nominal prices); Table 82: Japan Vitamins and Minerals company share by value, 2005-2006 (%); Table 83: Japan Vitamins and Minerals value, by company, 2005-2006 (JPY m nominal prices); Table 84: Japan Vitamins and Minerals expenditure per capita, 2001-2006 (JPY, nominal prices); Table 85: Japan Vitamins and Minerals forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 86: Japan Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 87: Japan Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 88: Japan Plasters & Bandages value, 2001-2006 (JPY m, nominal prices); Table 89: Japan Plasters & Bandages value forecast, 2006-2011 (JPY m, nominal prices); Table 90: Japan Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 91: Japan Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 92: Japan Plasters & Bandages brand share, by value, 2005-2006 (%); Table 93: Japan Plasters & Bandages value, by brand 2005-2006 (JPY m nominal prices); Table 94: Japan Plasters & Bandages company share by value, 2005-2006 (%); Table 95: Japan Plasters & Bandages value, by company, 2005-2006 (JPY m nominal prices); Table 96: Japan Plasters & Bandages expenditure per capita, 2001-2006 (JPY, nominal prices); Table 97: Japan Plasters & Bandages forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 98: Japan Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 99: Japan Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 100: Japan Medicated Skin Products value, 2001-2006 (JPY m, nominal prices); Table 101: Japan Medicated Skin Products value forecast, 2006-2011 (JPY m, nominal prices); Table 102: Japan Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 103: Japan Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 104: Japan Medicated Skin Products brand share, by value, 2005-2006 (%); Table 105: Japan Medicated Skin Products value, by brand 2005-2006 (JPY m nominal prices); Table 106: Japan Medicated Skin Products company share by value, 2005-2006 (%); Table 107: Japan Medicated Skin Products value, by company, 2005-2006 (JPY m nominal prices); Table 108: Japan Medicated Skin Products expenditure per capita, 2001-2006 (JPY nominal prices); Table 109: Japan Medicated Skin Products forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 110: Japan Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 111: Japan Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 112: Japan Other OTC Healthcare Products value, 2001-2006 (JPY m, nominal prices); Table 113: Japan Other OTC Healthcare Products value forecast, 2006-2011 (JPY m, nominal prices); Table 114: Japan Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 115: Japan Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 116: Japan Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 117: Japan Other OTC Healthcare Products value, by brand 2005-2006 (JPY m nominal prices); Table 118: Japan Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 119: Japan Other OTC Healthcare Products value, by company, 2005-2006 (JPY m nominal prices); Table 120: Japan Other OTC Healthcare Products expenditure per capita, 2001-2006 (JPY, nominal prices); Table 121: Japan Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 122: Japan Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 123: Japan Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 124: Japan Topical OTC Medicines value, 2001-2006 (JPY m, nominal prices); Table 125: Japan Topical OTC Medicines value forecast, 2006-2011 (JPY m, nominal prices); Table 126: Japan Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 127: Japan Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 128: Japan Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 129: Japan Topical OTC Medicines value, by brand 2005-2006 (JPY m nominal prices); Table 130: Japan Topical OTC Medicines company share by value, 2005-2006 (%); Table 131: Japan Topical OTC Medicines value, by company, 2005-2006 (JPY m nominal prices); Table 132: Japan Topical OTC Medicines expenditure per capita, 2001-2006 (JPY, nominal prices); Table 133: Japan Topical OTC Medicines forecast expenditure per capita, 2006-2011 (JPY, nominal prices); Table 134: Japan Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 135: Japan Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 136: Global OTC Healthcare market value, 2006; Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 138: Leading players - Top 5 countries; Table 139: Japan OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006; Table 140: Japan OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006; Table 141: Japan OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006; Table 142: Japan OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006; Table 143: Japan OTC Healthcare new product launches (reports) - Recent 5 launches; Table 144: Japan Key Facts; Table 145: Japan population, by age group, 2000-2005 (millions); Table 146: Japan population forecast, by age group, 2005-2010 (millions); Table 147: Japan population, by gender, 2000-2005 (millions); Table 148: Japan population forecast, by gender, 2005-2010 (millions); Table 149: Japan real GDP, 2000-2005 (JPY bn, 2005 prices); Table 150: Japan real GDP forecast, 2005-2010 (JPY bn, 2005 prices); Table 151: Japan nominal GDP, 2000-2005 (JPY bn, nominal prices); Table 152: Japan real GDP, 2000-2005 (US$ bn, 2005 prices); Table 153: Japan real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 154: Japan consumer price index, 2000-2005 (2000=100); Table 155: Japan consumer price index, 2005-2010 (2000=100); Table 156: Japan exchange rate, 2000-2005

More Japan Over-the-Counter Drugs Reports

Digestive Remedies in Japan by Euromonitor International
Value sales of digestive remedies declined by 2% in 2011. The continued economic downturn and consumers’ reduced dining at restaurants and bars discouraged sales of ...

Medicated Skin Care in Japan by Euromonitor International
Value sales of vaginal antifungals rose by 6% in 2011. Female consumers are switching from prescription to OTC medications due to the sensitive nature of ...

Herbal/Traditional Products in Japan by Euromonitor International
In Japan, kampo products are the most well-known type of herbal medicine, and they usually contain several unrefined medications in raw or natural form to ...

Ear Care in Japan by Euromonitor International
Tinnitus is the perception of sound within the human ear in the absence of corresponding external sound. There are various studies about tinnitus patients, and ...

Cough, Cold and Allergy (Hay Fever) Remedies in Japan by Euromonitor International
Value sales of antihistamines/allergy remedies (systemic) rose by 22% in 2011 due to very high pollen counts in Japan. It was reported that the dispersion ...

See all reports like this >>

More Japan Reports

D&B Country Report: Japan by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Plimsoll Portfolio Analysis - Guard Services (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Guard Services is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Plimsoll Portfolio Analysis - Business Consultants (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Business Consultants is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Plimsoll Portfolio Analysis - Land Developers (Japan) by Plimsoll Publishing Ltd.
The Plimsoll Portfolio Analysis - Land Developers is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance ...

Japan: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis of Japan, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

See all reports like this >>

OTC Healthcare in Japan to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service